Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women

Abstract

Literary data suggest apparently ambiguous interaction between menopausal status and obesity-associated breast cancer risk based on the principle of the carcinogenic capacity of estrogen. Before menopause, breast cancer incidence is relatively low and adiposity is erroneously regarded as a protective factor against this tumor conferred by the obesity associated defective estrogen-synthesis. By contrast, in postmenopausal cases, obesity presents a strong risk factor for breast cancer being mistakenly attributed to the presumed excessive estrogen-production of their adipose-tissue mass. Obesity is associated with dysmetabolism and endangers the healthy equilibrium of sexual hormone-production and regular menstrual cycles in women, which are the prerequisites not only for reproductive capacity but also for somatic health. At the same time, literary data support that anovulatory infertility is a very strong risk for breast cancer in young women either with or without obesity. In the majority of premenopausal women, obesity associated insulin resistance is moderate and may be counteracted by their preserved circulatory estrogen level. Consequently, it is not obesity but rather the still sufficient estrogen-level, which may be protective against breast cancer in young adult females. In obese older women, never using hormone replacement therapy (HRT) the breast cancer risk is high, which is associated with their continuous estrogen loss and increasing insulin-resistance. By contrast, obese postmenopausal women using HRT, have a decreased risk for breast cancer as the protective effect of estrogen-substitution may counteract to their obesity associated systemic alterations. The revealed inverse correlation between circulatory estrogen-level and breast cancer risk in obese women should advance our understanding of breast cancer etiology and promotes primary prevention measures. New patents recommend various methods for the prevention and treatment of obesity-related systemic disorders and the associated breast cancer.

Obesity and cancer: inflammation bridges the two

“…This hypothesis, however, fails to fully explain the relationship between body mass and breast cancer incidence and poor clinical outcome, as the relationship is present in ER-negative breast cancers [34,36]. Also, some recent studies have indicated that circulating estrogens may protect against the development of breast cancer in obese women [40]. …”

Apoptotic Bax Gene Expression in Glioblastoma Cells Exposed to Estradiol valerate

“…It has also been reported that estrogen may have protecting effects against various cancers [9]- [10]. The research revealed that estrogen has improving effects on glioblastoma treatment [11].…”

A Computational Study of Anticancer Activity of Curcumin Derivatives Using in silico Drug Designing and Molecular Docking Tools

“…Docking studies enhanced ligand precision and even though drug produces unsatisfactory desired effects by binding with another macromolecules, it is possible to dwindle affinity to the opposing site so as to achieve prolonged curative effect [25]. The computational scrutiny of the selected 11 curcuminoids and the standard drug megestrol acetate was useful to identify its likeliness to the protein selected p53.…”